Offline
| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
Marksans Pharma
BSE Announcements on Marksans Pharma
Posted by :
MMB MessengerTracked by: 0 Boarder
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 02, 2008, inter alia, has taken following decisions:
1. Appointment of Statutory Auditors of the Company subject to the approval of the members of the Company.
2. Approval of ESOP scheme for the employees of the Company.
3. Approval of the notice of the Annual General Meeting and fixation of the day, date, time and place of the Annual General Meeting.
5. Fixation of Dock Closure dates for the purpose of the Annual General Meeting....
NSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on September 02, 2008 the following decisions were taken: (1) Adoption of Audited Annual Accounts of the Company for the year ended March 31, 2008, along with Auditors report, Directors report, Corporate Governance Report and management Analysis and Discussion report. (2) Appointment of Statutory Auditors of the Company subject to the approval of the members of the Company. (3) Approval of ESOP scheme for the employees of the Company. (4) Approval of the notice of the Annual General Meeting and fixation of the day, date, time and place of the Annual General Meeting. (5) Fixation of Book Closure dates for the purpose of the Annual General Meeting....
TARGET RS 35-40
Posted by : vkk43Tracked by: 0 Boarder
Any specific news on this share....
In reply to:
TARGET RS 35-40
Posted by :
300567
BUY FOR THE ABOVE TARGET IN NEST 20-30 TRADING SESSIONS 
TARGET RS 35-40
Posted by : 300567Tracked by: 0 Boarder
BUY FOR THE ABOVE TARGET IN NEST 20-30 TRADING SESSIONS...
SHORT TERM AND LONG TERM TARGETS
Posted by :
mallicaTracked by: 0 Boarder
What are short term and long term targets for marksans pharma?
...
Marksans Pharma
Posted by : zoombusinessTracked by: 0 Boarder
Marksans Pharma surges on overseas acquisition
Marksans Pharma rose 2.58% to Rs 19.90 on BSE after the company said it has acquired 100% stake in Relonchem, a leading UK based generic pharmaceutical company, for an undisclosed sum.
The company made this announcement before trading hours today, 28 August 2008.
On BSE, 82,571 shares were traded in the counter. The scrip had an average daily volume of 29.52 lakh shares in the past one quarter.
The stock hit a high of Rs 19.95 and a low of Rs 19.80 so far during the day. The stock had hit a 52-week high of Rs 35.16 on 4 January 2008 and a 52-week low of Rs 4.60 on 29 August 2007.
The small-cap company had outperformed the market over the past one month till 27 August 2008, gaining 19.98% compared to the Sensex’s return of 0.15%. It had also outperformed the market in the past one quarter, declining 2.02% compared to Sensex’s decline of 12.16%.
The company has an equity capital of Rs 35.94 crore. Face value per share is Rs 1.
The current price of Rs 19.90 discounts its Q1 June 2008 annualised EPS of Rs 0.76, by a PE multiple of 26.18.
Relonchem clocked sales of $32 million and adjusted earnigns before interest, taxes, depreciation and amortization (EBITDA) of $5 million in the financial year 2007.
The acquisition will give Marksans Pharma an immediate sales and marketing front-end access to the highly regulated and lucrative generic medicines market in UK and Europe. The acquisition is on a debt free, cash free basis. The company plans to use a combination of cash in hand and debt to fund the acquisition.
Marksans Pharma’s net profit surged 197.8% to Rs 6.79 crore on 13.6% increase in net sales to Rs 54.12 crore in Q1 June 2008 over Q1 June 2007.
The company is engaged manufacturing and selling pharmaceuticals.
courtesy C M...
BSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2008 has decided to acquire entire shareholding of M/s. Relonchem Ltd....
BSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Ltd has informed BSE regarding a Press Release dated August 27, 2008 titled "Marksans Pharma acquires UKs leading generic pharma company Relonchem Ltd"...
NSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Limited has informed the Exchange that "Marksans Pharma Limiteds subsidiary, Marksans Pharma (UK) Limited, has entered into a definitive agreement to acquire 100% of the share capital of RelonCehm Limited." The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on September 02, 2008, inter alia, to consider and adopt the following:
1. Audited Annual Accounts of the Company for the year ended March 31, 2008, along with Auditors Report, Directors Report, Corporate Governance Report and management Analysis and Discussion Report.
2. To consider appointment of Statutory Auditors of the Company.
3. To consider and approve ESOP scheme for the employees of the Company.
4. To approve the draft of notice of the Annual General Meeting.
5. Fix the day, date, time and place of the Annual General Meeting.
6. To fix the book Closure dates for the purpose of the Annual General Meeting....
operator driven stock
Posted by :
ash...!!Tracked by: 1 Boarder
target is 30 hold on for few days it should touch it by september 15th. though nothg is sure in this market but this news is coming from the operators.
and please exit when you feel you have made enough money out of it....
In reply to:
operator driven stock
Posted by : mallica
would appreciate ur views on the exit price as I have bought this scrpt @20.35.Thanks.
operator driven stock
Posted by : jdosvdTracked by: 1 Boarder
Mallica,this stock was below 50 levels in March last year .......then slowly in three months went to 350 and then again came down.......one should buy this at lows eg recently it reached 11 levels and also more recently reached 16 levels to be exited around 20-22 levels.Regards.Jd....
In reply to:
operator driven stock
Posted by : mallica
would appreciate ur views on the exit price as I have bought this scrpt @20.35.Thanks.
operator driven stock
Posted by : mallicaTracked by: 1 Boarder
would appreciate ur views on the exit price as I have bought this scrpt @20.35.Thanks....
In reply to:
operator driven stock
Posted by : ash...!!
i think the current rally of this script shows its on hit list of operators now.
if this continues i believe we can see some new high and lows for this stock!
just watch out..!!
BSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
With reference to the earlier announcement dated August 19, 2008 regarding EGM on Sep 10, 2008, Marksans Pharma Ltd has now informed BSE that in the said notice of the EGM the amount to be receive by the Company from issue of 8400241 Equity shares of Re 1/- each of the Company to M/s. Barnacle LLC, on preferential allotment basis, is mentioned as Rs "16,89,87,000/-". However the actual amount is Rs "16,90,12,849/-". This is due to typographical and printing error on the part of the Company.
The said amount should be read as Rs "16,90,12,849/-"....
BSE Announcements on Marksans Pharma
Posted by : MMB MessengerTracked by: 0 Boarder
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2008, inter alia, authorized to offer, issue and allot upto 84,00,241 Equity Shares of Re 1/- (Rupee one) each fully paid at a premium of Rs 19.12/- (Rupees nineteen paise twelve only) per Equity Share aggregating to Rs 16,90,12,849/- (Rupees sixteen crores ninety lakhs twelve thousand eight hundred and forty nine only), (the "Equity Shares") in the Share Capital of the Company to M/s. Barnacle LLC, on preferential allotment basis to the extent and in one or more tranches and in the manner as may be decided by the Board in this behalf, subject to necessary provisions & approvals....
3 queries on Marksans Pharma
see moreMore from the Pharmaceuticals Sector
Boarders tracking Marksans Pharma
News Updates on Marksans Pharma
Explore Moneycontrol
